Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.
As a guest to ChinaBio® Today, you have access to summaries of over 2500 articles including our archives. You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.
Baiyunshan Pharma Raises $1.6 Billion in Secondary Offering | January 13, 2015
Hanmi Invests $20 Million in Allegro for Eye Disease Drug | January 13, 2015
WuXi PharmaTech Acquires Genomics Company NextCODE for $65 Million | January 9, 2015
Fosun Pharma Invests $35 Million in Amerigen Pharma | January 9, 2015
What Didn't Happen in 2014: China Life Science IPOs | January 2, 2015
Otsuka In-licenses Asian Rights to Cancer Drug from Ariad for $77.5 Million | December 26, 2014
>> See all top stories...
ChinaBio in the News